The role of alemtuzumab in the development of secondary autoimmunity in multiple sclerosis: a systematic review

The role of alemtuzumab in the development of secondary autoimmunity in multiple sclerosis: a systematic review

Abstract Background Secondary autoimmune disease (SAID) in the context of alemtuzumab treatment is one of the main safety concerns that may arise following administration in people with multiple sclerosis (pwMS). Contributing factors underlying this adverse event are not well understood. The purpose...

Full description

Saved in:
Bibliographic Details
Main Authors: Sofia Jimenez-Sanchez, Rebekah Maksoud, Natalie Eaton-Fitch, Sonya Marshall-Gradisnik, Simon A. Broadley
Format: Article
Language:English
Published: BMC 2024-11-01
Series:Journal of Neuroinflammation
Subjects:
Multiple Sclerosis
Alemtuzumab
Secondary autoimmune disease
Online Access:https://doi.org/10.1186/s12974-024-03263-9
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items

Similar Items